Company intelligence / Profile preview

Gilliam Capital

Concord, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Gilliam Capital is a private life science investment firm based in the Boston area. Publicly available information indicates that the firm was co-founded by John Conley and focuses on investing in life science and healthcare companies rather than operating as a drug developer, pharmaceutical manufacturer, or healthcare services company. The company appears to be a small, active LLC registered in Massachusetts. There is no evidence from available public sources that Gilliam Capital has an internal therapeutic pipeline, proprietary drug platform, or clinical-stage development programs. It is best characterized as a healthcare-focused investment vehicle or investment firm rather than an operating biotech company.

Industry: Investors

Beyond the preview

Go deeper on Gilliam Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gilliam Capital.

Explore the full profile